EYPT
EyePoint, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.39
−2.48%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 39.51x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.20x
- Price / sales
- 12.06x
- Price / cash flow
- -0.13x
Enterprise value
- Enterprise value
- -$124.5M
- EV / sales
- -44.63x
- EV / EBITDA
- 0.42x
- EV / EBIT
- 0.39x
- Market cap
- $33.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026